Searched for
GLP 1 MEDICINES
GLP-1 and fertility: Could weight-loss medicines help women conceive? Here's what new reports revealinsulin resistance can disrupt reproductive hormones. For women with polycystic ovary syndrome (PCOS), ovulation may become irregular. Gett...
Assessing products to counter side effects of GLP-1, says Bayer's TrianaBayer AG plans to expand its consumer health business in India significantly by 2030. The company aims to triple its revenue in the Indian ...
WHO says medicines, surgery not first-line treatment for childhood obesityThe World Health Organization has released guidelines on treating obesity among children and adolescents. It emphasizes structured diets, p...
Nobel 2026: Ozempic, Mounjaro research tipped for medicine prizeThe 2026 Nobel season is set to reveal the winners of various prestigious awards, starting with medicine. The medicine prize is anticipated...
‘India’s biotech ecosystem holds tremendous promise’: Eli Lilly CEOEli Lilly has experienced significant growth, reaching a market capitalization over $1 trillion. The company aims to maintain its leadershi...
From Jab to Pills: Novo Nordisk, Eli Lilly set to take obesity drug battle to IndiaIndia’s obesity drug market is set for a new phase as Novo Nordisk’s oral Wegovy and Eli Lilly’s oral GLP-1 orforglipron are expected to la...
2026 Nobel Prize Predictions: From GLP-1 drugs and CAR-T therapy to gene editing, these breakthroughs could take centre stagePredictions for the 2026 Nobel Prizes in science highlight significant contributions in areas like GLP-1 research and cancer therapies. Car...
Frances Bones was buried at Carlisle in 1895: How researchers finally traced her Comanche family after 131 years and returned her remains to OklahomaFrances Bones was a Native American child who died at the Carlisle Indian Industrial School in 1895. After more than a century, her remains...
Women tip the scale as weight-loss boom reaches tier-II citiesWhile startups such as General Catalyst-backed Voy and Mumbai-based Metago are seeing higher demand from women, Elevate Now, backed by Tita...
GLP-1 users are suing over vision loss: What does the evidence really show?Dozens of patients have taken legal action against drug manufacturers, filing personal injury lawsuits that allege they were not adequately...
Zydus gearing up for next phase of growth, eyeing new areas: Sharvil Patel, MD"From 2030 and beyond, we will see strong earnings from pure discovery-led business, which is our central business, our oncology business a...
Ozempic maker Novo Nordisk sets sights on hair-loss marketThe condition is part of a list of areas, including addiction and menopause, where Novo sees potential overlap with either its core scienti...
MF Tracker: HDFC Pharma & Healthcare Fund tops equity MFs at 25% in 1 year. Should investors chase the rally?HDFC Pharma and Healthcare Fund recorded an impressive 25% return in the last year, surpassing its category average across various time fra...
Sandoz bets big on biosimilars, aims to double group sales by 2035Sandoz plans to more than double annual net sales by 2035, with biosimilars leading growth. The company will expand its biosimilar portfoli...
Growing peptide trend raises safety concerns among doctorsDoctors express concern over popular injectable peptides for various health benefits. They caution that established peptide medicines diffe...
Eli Lilly’s Mounjaro wins FDA approval for a major new cardiovascular benefitEli Lilly's Mounjaro received FDA approval for reducing heart attack and stroke risks. This new indication expands its use beyond diabetes ...
White House to announce new drug pricing deals with biotechs: ReportThe Trump administration is expected to announce voluntary drug-pricing agreements with midsize biotech companies, requiring discounts for ...
Eli Lilly launches oral weight-loss pill Foundayo in UKEli Lilly has launched its oral weight management pill Foundayo in the United Kingdom. This new treatment, chemically known as orforglipron...
GLP-1 drugs create new market for collagen, protein and beauty products in IndiaThe rising use of GLP-1 weight-loss drugs such as Ozempic and Mounjaro is creating a new consumer market in India, with companies developin...
In 2019, research began with users of anti-diabetes treatment medicines, now study shows side effect could be hair lossDiabetes treatment: The researchers said while the study was a rigorous one, based on high quality data from a large representative cohort,...